| Bio-M AG Bio-M is a financing service and consulting company with the aim to promote the development of the BioTech-Region München. It is the “one-stop shop” for start-up biotech companies seeking financial support, business advice and the right contacts. Bio-M has set up a finance program to provide promising biotechnology companies with venture capital in the initial seed and start-up phases. |
 |
|
BioTOP is a joint initiative established by the federal states of Berlin and Brandenburg as well as the regional industry. The Aktionszentrum BioTOP is developing strategies aiming at a clear-cut commercial vision for biotechnology in the Berlin-Brandenburg area. Furthermore we offer various free services to support biotech start up companies and those who wish to settle in the region. The BioTOP-Aktionszentrum's team is at your disposal
for all matters regarding biotechnology in Berlin and Brandenburg: On the BioTOP homepage (www.biotop.de)
you will find a comprehensive overview of Berlin-Brandenburg's biotech
scene. The searchable database BioInfooffers detailed profiles of
+150 biotech companies and of over 200 teams of scientists. |
 |
|
Citigate Dewe Rogerson (CDR) is the leading international consultancy specialising exclusively in financial and corporate communications across the UK, Europe, North America and Asia. CDR is a member of Incepta Group plc, the international marketing and communications group. With Headquarters based in London, Incepta Group operates out of 20 countries worldwide. Incepta Group currently employs over 2,000 members of staff and services circa 3,000 clients. CDR has a dedicated Pharma & Biotech team with more than 30 years combined experience in the sector and a unique mix of skills: corporate and financial PR and investor relations, finance, journalism and academic science. The team provides sector expertise and forms an integrated part of Citigate Dewe Rogerson, benefiting from CDR’s overall strength and from the cross-fertilisation of ideas across sectors. The CDR Pharma & Biotech team has an established track record in working with biotechnology companies at all stages in development. As well as core skills in financial calendar work, transactions support, financial PR and media relations, the team has extensive experience in branding, design and new media consultancy. Current clients include global top-five biotechs, specialty private equity and VC firms, listed companies in the UK and Europe, and numerous emerging businesses in the UK, France, Germany and Scandinavia. |
 |
|
Danish Biotech - The Association of Biotechnology Industries* works to improve conditions for biotechnological research and production in Denmark, and to further the common interests of members, nationally and internationally. Members of the association are companies with research and development in bio-industry and with production involving biotechnology. |
 |
|
FINANCE is a monthly magazine published by FINANCIAL Gates GmbH, part of the Frankfurter Allgemeine Zeitung GmbH publishing group. It is the premier authoritative publication on all aspects of corporate finance in Germany. Topics covered include mergers and acquisitions, venture capital, stock market listings, buy-outs and private equity. FINANCE focuses in particular on issues of relevance to German medium-sized and start-up companies. FINANCE is also read by the M&A and corporate finance experts of major companies. The guaranteed monthly circulation is 25,000 copies. For subscriptions please call +49 40 3007 25 34, or fax +49 40 3007 3070. |
 |
|
Founded in 1998 GoingPublic Media AG is today one of the leading companies in Germany publishing magazines on venture capital and corporate finance contents as well as small and mid cap research. In addition to the monthly issued GoingPublic Magazin and its well known yearly special editions like “Corporate Finance & Private Equity Guide”, “Biotechnology “or “Investor Relations” which are largely meant as reference books, the company publishes the likewise monthly VentureCapital Magazin. Founded in 2000 as a supplement to the GoingPublic Magazin, VentureCapital Magazin (www.venturecapital.de) started into a new era as an independent publication in July 2002 and focuses on private equity, buy-outs and M&A. The brand is a synonym for growth, innovation, entrepreneurial culture and equity financing. Special topics are additionally treated in supplements and special editions (“Nanotechnology”, “Mittelstandsfinanzierung” etc). Furthermore GoingPublic Media operates the online-service GoingPublic Online (www.goingpublic.de) and the corporate publishing division (GoingPublic Services) publishes about 10 magazines and newsletters a year for well-known venture capital companies and financial institutions. Since May 2003 the company publishes a third magazine called “Smart Investor” (www.smartinvestor.de). With its critical research and independent thinking, Smart Investor is an ambitious, fast growing magazine for the contrarian investor seeking information beyond the mainstream. All publications are printed in German. Contact: Orders and subscriptions: For more information, please contact us at +49-8171-419650 or info@goingpublic.de |
 |
|
Kirchhoff Consult is a consulting company and
design agency. We are specialized in equity consulting, financial
communication and corporate communication. We are leaders in capital
market transactions and annual reports. We advise our clients with
teams Germany, Switzerland and Austria. In UK/USA we cooperate with
specialized partners. Among our references are companies like Allianz, Bayer, Berlin Heart, BWM, EUWAX, Genmab, Fraport, Hero, Intercell, Jelmoli, Lanxess, LION bioscience, MAN, Marseille-Kliniken, MediGene, Nobel Biocare, noxxon Pharma, Otto Bock Health Care GmbH, Phoenix Mecano, Sanochemia Pharmazeutika, Sartorius, Thiel Logistik, Wincor Nixdorf, Züblin Immobilien Holding AG. Our services comprise: Kirchhoff Consult (Schweiz) AG Contact person |
 |
|
Northbank Communications is a full service communications consultancy focused on science-based companies. We believe that these companies perhaps more than most, need high quality communications to build corporate value and promote their leading edge products, technologies and services. Northbank has offices in London, Congleton (near Manchester) and Munich. We provide expert counsel to our clients through a range of specialist business consulting, communications and design services appropriate to their needs. We also offer outreach programmes to media, industry, public, financial and investment communities. We provide ongoing support through all stages of a company’s development – from start-up or early stage, through listing and beyond as a publicly quoted company. In addition, we can assist publicly funded organisations and initiatives. Our understanding of the technical, commercial and financial issues facing our clients, alongside the expertise of our team and broad network of contacts, means we are able to offer a personalised, highly effective and value for money service. |
 |
|
The Trout Group provides investor relations and strategic advisory services solely to the life science industry. We have a global reach, with offices in New York, San Francisco and Boston and with advisors in Israel and Munich. Our team of professionals advises both public and private companies in the U.S., Canada, Europe, Israel and Australia. Trout’s clients include leading global biotechnology, specialty pharmaceutical, medical device and diagnostic companies. Our goal-oriented, team approach has been successful in creating and executing investor relations programs for nearly 100 companies. Intellectual Capital Relationship Capital More than anything, The Trout Group is dedicated to providing the support needed to develop the strategic plan for a company and, more importantly, working to implement the plan. We will execute the strategies we develop with our clients. Our team will not just design a plan for the Company, but we will work with the Company “hands-on” to reach our goals. What Sets The Trout Apart? |
 |